{
  "name": "Vertex Pharmaceuticals",
  "slug": "vertex-pharmaceuticals",
  "ticker": "VRTX",
  "fetched_at": "2025-11-24T12:24:31.376850+00:00",
  "news": [
    {
      "title": "The Bull Case for Vertex Pharmaceuticals (VRTX) Could Change Following Strong Kidney Data and Regulatory Progress - Yahoo Finance",
      "link": "https://news.google.com/rss/articles/CBMiiwFBVV95cUxQZjBOblp5SzRrVlRSaFJDSDRZX2M0X3BJdXgyVGEwVHJJUVNnbHJra2hBTTFSLVZFeVpfbFI2N1pPYVo3UkU2ZEVZRUdmdWdDdGhTcHd2MkhMTElYOFNUM2lWOHMzd1lvUFlWNHF2NDNMWU9VMFVuQ3hZbFRLdjVVNTlqd1VyZnJKa1Zr?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiiwFBVV95cUxQZjBOblp5SzRrVlRSaFJDSDRZX2M0X3BJdXgyVGEwVHJJUVNnbHJra2hBTTFSLVZFeVpfbFI2N1pPYVo3UkU2ZEVZRUdmdWdDdGhTcHd2MkhMTElYOFNUM2lWOHMzd1lvUFlWNHF2NDNMWU9VMFVuQ3hZbFRLdjVVNTlqd1VyZnJKa1Zr?oc=5\" target=\"_blank\">The Bull Case for Vertex Pharmaceuticals (VRTX) Could Change Following Strong Kidney Data and Regulatory Progress</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Yahoo Finance</font>",
      "published": "2025-11-10T08:00:00+00:00",
      "source": "Yahoo Finance"
    },
    {
      "title": "Home - Vertex Pharmaceuticals",
      "link": "https://news.google.com/rss/articles/CBMiRkFVX3lxTFA5V0I2MlFxR2EzeXBQQUdHWUt1bmVXVXZ1eFRHSUtlZTBnaDZOQjBoa3AzcU81aFZJa1dOSHFFcHRpamxqNVE?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiRkFVX3lxTFA5V0I2MlFxR2EzeXBQQUdHWUt1bmVXVXZ1eFRHSUtlZTBnaDZOQjBoa3AzcU81aFZJa1dOSHFFcHRpamxqNVE?oc=5\" target=\"_blank\">Home</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Vertex Pharmaceuticals</font>",
      "published": "2025-06-02T15:34:51+00:00",
      "source": "Vertex Pharmaceuticals"
    },
    {
      "title": "Why Vertex Skidded Despite Its Beat-And-Raise Quarter - Investor's Business Daily",
      "link": "https://news.google.com/rss/articles/CBMimwFBVV95cUxPTm9kVjVUVVFCTkJyZlZxUmdoWkFPVGl1UVBvbnRaanNlQXBCRm1RYjYyYlVDWi12NEZLa3FHMDJ5S1ZjLXc5VUxZTjV1ZVliRi14MkxkV0ZQcFdCS09tZ1JqSDlWeG1Qb1R6WUNkU0E1TjF2SGpfc3A1SnR3Q2lWb21OalN0bGNhdkJRYmRtVlh3Y21jT25yMXlSTQ?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMimwFBVV95cUxPTm9kVjVUVVFCTkJyZlZxUmdoWkFPVGl1UVBvbnRaanNlQXBCRm1RYjYyYlVDWi12NEZLa3FHMDJ5S1ZjLXc5VUxZTjV1ZVliRi14MkxkV0ZQcFdCS09tZ1JqSDlWeG1Qb1R6WUNkU0E1TjF2SGpfc3A1SnR3Q2lWb21OalN0bGNhdkJRYmRtVlh3Y21jT25yMXlSTQ?oc=5\" target=\"_blank\">Why Vertex Skidded Despite Its Beat-And-Raise Quarter</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Investor's Business Daily</font>",
      "published": "2025-11-04T08:00:00+00:00",
      "source": "Investor's Business Daily"
    },
    {
      "title": "Vertex to Participate in the Citi’s 2025 Global Healthcare Conference on December 3 - Business Wire",
      "link": "https://news.google.com/rss/articles/CBMi1gFBVV95cUxQc1FtQkZ0NEg0V1pIOUtmRWxTSGc1cjRGamx1VWh3c2FXOFhpaGQ4TDBONUNHeEZhRHpTcG13a3BxdThGbFRUM29tQVRZNXBnZXZNbzFiTVI2ZzZGUEZKekJ0b1ZFeVZUZ2l2N21pX3RTODdYRVo5MFFxMDJILXNfOEgtWmdfTF9hNy1hS0dtb2kwT29HWFJiemVoWkVjRGwzcEZycXBvWE1rYWRkWnNuSm1pWVJybVZFSlZyY1g1cEYyMFUtcFJ4a3pxckk1UDBhTHpPOW13?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMi1gFBVV95cUxQc1FtQkZ0NEg0V1pIOUtmRWxTSGc1cjRGamx1VWh3c2FXOFhpaGQ4TDBONUNHeEZhRHpTcG13a3BxdThGbFRUM29tQVRZNXBnZXZNbzFiTVI2ZzZGUEZKekJ0b1ZFeVZUZ2l2N21pX3RTODdYRVo5MFFxMDJILXNfOEgtWmdfTF9hNy1hS0dtb2kwT29HWFJiemVoWkVjRGwzcEZycXBvWE1rYWRkWnNuSm1pWVJybVZFSlZyY1g1cEYyMFUtcFJ4a3pxckk1UDBhTHpPOW13?oc=5\" target=\"_blank\">Vertex to Participate in the Citi’s 2025 Global Healthcare Conference on December 3</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Business Wire</font>",
      "published": "2025-11-19T21:00:00+00:00",
      "source": "Business Wire"
    },
    {
      "title": "Vertex Pharma’s Stock Has Tumbled. Earnings Will Stop the Pain. - Barron's",
      "link": "https://news.google.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?oc=5",
      "summary": "<a href=\"https://news.google.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?oc=5\" target=\"_blank\">Vertex Pharma’s Stock Has Tumbled. Earnings Will Stop the Pain.</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Barron's</font>",
      "published": "2025-10-31T07:00:00+00:00",
      "source": "Barron's"
    },
    {
      "title": "TIME100 Most Influential Companies 2025: Vertex Pharmaceuticals - Time Magazine",
      "link": "https://news.google.com/rss/articles/CBMiiwFBVV95cUxQVkY3MnJaQ3p3Mk5LZGVBRXhDY0ZmaF9CS21MZWJSb01RRTNUN0JHUE9lTGRrckh6QnkxUGhXcm1yNk81WmM5aVdxZVdTdEFTMTBaN0E0MndpNHRLWjBJd2RrZ09JT3ZDaE04d21ucmVkcnl4aGFIcFlaN1QxcGtiT1lYQ2ppX202b2pr?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiiwFBVV95cUxQVkY3MnJaQ3p3Mk5LZGVBRXhDY0ZmaF9CS21MZWJSb01RRTNUN0JHUE9lTGRrckh6QnkxUGhXcm1yNk81WmM5aVdxZVdTdEFTMTBaN0E0MndpNHRLWjBJd2RrZ09JT3ZDaE04d21ucmVkcnl4aGFIcFlaN1QxcGtiT1lYQ2ppX202b2pr?oc=5\" target=\"_blank\">TIME100 Most Influential Companies 2025: Vertex Pharmaceuticals</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Time Magazine</font>",
      "published": "2025-06-26T07:00:00+00:00",
      "source": "Time Magazine"
    },
    {
      "title": "Vertex Pharmaceuticals: JOURNAVX Prescription Demand And Povetacicept Developments Warrant \"Strong Buy\" - Seeking Alpha",
      "link": "https://news.google.com/rss/articles/CBMi2AFBVV95cUxOcHp4RTRLVnBPUVVnZkFFY2ZsdzhETENteE5wZ0xjZDZyR1J4WEZycXBIWUozZ284VGpEWFU0OUdjQmFNZGVjSW5mVzZlY3kzM2pTWkZWZ3plckNDUE5VZHMxX0tvTzc0cHp0OFdpNENmT3Z4YjFxc1VMWTNta05uVXhhSjhBX09JU0lKRlZCVmpTcVI4RnVBeXROWE1hbXhPQm94RVRzdlVoVDNFSmUyUkdFX0hiSVdSbWwzVFdzd051Tl85ZjlUMHJSSUFKZUdHajRvN21VVU8?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMi2AFBVV95cUxOcHp4RTRLVnBPUVVnZkFFY2ZsdzhETENteE5wZ0xjZDZyR1J4WEZycXBIWUozZ284VGpEWFU0OUdjQmFNZGVjSW5mVzZlY3kzM2pTWkZWZ3plckNDUE5VZHMxX0tvTzc0cHp0OFdpNENmT3Z4YjFxc1VMWTNta05uVXhhSjhBX09JU0lKRlZCVmpTcVI4RnVBeXROWE1hbXhPQm94RVRzdlVoVDNFSmUyUkdFX0hiSVdSbWwzVFdzd051Tl85ZjlUMHJSSUFKZUdHajRvN21VVU8?oc=5\" target=\"_blank\">Vertex Pharmaceuticals: JOURNAVX Prescription Demand And Povetacicept Developments Warrant \"Strong Buy\"</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Seeking Alpha</font>",
      "published": "2025-11-04T08:00:00+00:00",
      "source": "Seeking Alpha"
    },
    {
      "title": "After pain setback, Vertex spotlights renal portfolio in expectation-beating Q3 - FirstWord Pharma",
      "link": "https://news.google.com/rss/articles/CBMiU0FVX3lxTFBWU2ZGNElLRnBuSW1iZmRpSndqRW82bmdveVlSYjNTSW9qR29CUHlJNlI0Z3BSWWlnY0Z0NnJFQzc4cktDakZnYWpRZ0xXc1NORGlr?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiU0FVX3lxTFBWU2ZGNElLRnBuSW1iZmRpSndqRW82bmdveVlSYjNTSW9qR29CUHlJNlI0Z3BSWWlnY0Z0NnJFQzc4cktDakZnYWpRZ0xXc1NORGlr?oc=5\" target=\"_blank\">After pain setback, Vertex spotlights renal portfolio in expectation-beating Q3</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">FirstWord Pharma</font>",
      "published": "2025-11-03T08:00:00+00:00",
      "source": "FirstWord Pharma"
    }
  ],
  "product_launches": [
    {
      "title": "Strong Product Launches and Upbeat Guidance Could Be a Game Changer for Vertex Pharmaceuticals (VRTX) - Yahoo Finance",
      "link": "https://news.google.com/rss/articles/CBMijgFBVV95cUxNOFZFNHZzSk1rSnJWVTEwWExLd1FvWVBPUkVkTV9TRG1oUWdTbWgzbWNkdlA3MkVLNmVra3NUUWhBQWFXZ3c5LVNxZFRkWDhkMUZ1QVlUXzg3ZEZwOHY3TTRjMEYxUjlwZFhYVW84QUVXX0lQaTZVbDN4Qk5WM1NQX0EwSVJXZ2piZXl4d3ZB?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMijgFBVV95cUxNOFZFNHZzSk1rSnJWVTEwWExLd1FvWVBPUkVkTV9TRG1oUWdTbWgzbWNkdlA3MkVLNmVra3NUUWhBQWFXZ3c5LVNxZFRkWDhkMUZ1QVlUXzg3ZEZwOHY3TTRjMEYxUjlwZFhYVW84QUVXX0lQaTZVbDN4Qk5WM1NQX0EwSVJXZ2piZXl4d3ZB?oc=5\" target=\"_blank\">Strong Product Launches and Upbeat Guidance Could Be a Game Changer for Vertex Pharmaceuticals (VRTX)</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Yahoo Finance</font>",
      "published": "2025-08-22T07:00:00+00:00",
      "source": "Yahoo Finance"
    },
    {
      "title": "Vertex’s new pain, blood disorder drugs miss Wall Street expectations - BioPharma Dive",
      "link": "https://news.google.com/rss/articles/CBMimgFBVV95cUxPSzdmS1NOZmlSUk5NZGNNbXdJdi1FajV2ZzVYQU5zaXVxVEV3RnFqNG1MUk9EMEtBT0h1Z1JpOEJsQU1Uek4wRUQtZ1dwc3NxVXlrU2dJbDdNNnplVUxrWkJzMHFreHZqUmFOYktWY2ZLLWtBV2tJZGNvSXFkdGVETXNiNkd1UHR2SFQxTmFIdktQSzFhbzc5a1BR?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMimgFBVV95cUxPSzdmS1NOZmlSUk5NZGNNbXdJdi1FajV2ZzVYQU5zaXVxVEV3RnFqNG1MUk9EMEtBT0h1Z1JpOEJsQU1Uek4wRUQtZ1dwc3NxVXlrU2dJbDdNNnplVUxrWkJzMHFreHZqUmFOYktWY2ZLLWtBV2tJZGNvSXFkdGVETXNiNkd1UHR2SFQxTmFIdktQSzFhbzc5a1BR?oc=5\" target=\"_blank\">Vertex’s new pain, blood disorder drugs miss Wall Street expectations</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">BioPharma Dive</font>",
      "published": "2025-11-04T08:00:00+00:00",
      "source": "BioPharma Dive"
    },
    {
      "title": "Vertex Pharmaceuticals Stock is Down 4% Despite Strong Q3 Results - TIKR.com",
      "link": "https://news.google.com/rss/articles/CBMipAFBVV95cUxNWmctaU5ocDNJQkhYeWU1TE9id3plcjdPcE1jR0NYZ2hFMVp6VXJtbzRSMEVRdGo3Z1VYaElRVzlJQ2JOV2F6OFJORlJudEJQMVhzMDExMUZ4Nnc2dlNIaWhjbVJPa2tCVlZzOGVRcmUyVDhfWi1kM2liNTlINmhlN2lRUHZKSEhXWWdCakVkQ0Vhb2l6SElFdzFfdHFJcF9qUy1KaQ?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMipAFBVV95cUxNWmctaU5ocDNJQkhYeWU1TE9id3plcjdPcE1jR0NYZ2hFMVp6VXJtbzRSMEVRdGo3Z1VYaElRVzlJQ2JOV2F6OFJORlJudEJQMVhzMDExMUZ4Nnc2dlNIaWhjbVJPa2tCVlZzOGVRcmUyVDhfWi1kM2liNTlINmhlN2lRUHZKSEhXWWdCakVkQ0Vhb2l6SElFdzFfdHFJcF9qUy1KaQ?oc=5\" target=\"_blank\">Vertex Pharmaceuticals Stock is Down 4% Despite Strong Q3 Results</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">TIKR.com</font>",
      "published": "2025-11-04T08:00:00+00:00",
      "source": "TIKR.com"
    },
    {
      "title": "VRTX Q3 Deep Dive: New Product Launches and Pipeline Progress Shape Outlook - Markets Financial Content",
      "link": "https://news.google.com/rss/articles/CBMi4AFBVV95cUxNZ3AtR3VETG02RC1BVDZrWlJxNXd4YXM1Y1VueUkzTnUzOW9nLWpJNW0tcnhkcDh4UVBJT2hZeU9uSGgyX0VkWGRVVjdEZEZ6ci00dy1NWTU1OXBfbnlFY0Vycy1tSDVZeWlKdXAtMUNtUGR3U1dKMXlMc2pQMkNPYjV6ZGhYRmlsOHJVcHRKX2JaSWxNZHlTRkMtVzh6S1Zyc0x2eXh1V2ZsSEJNWWpHTFAxdGlpSFJoMU9QVG1TMDBOLTZEVDhvQWwzbHMwMm5TbEs4ZjBuMTZYcnNfSU9pZQ?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMi4AFBVV95cUxNZ3AtR3VETG02RC1BVDZrWlJxNXd4YXM1Y1VueUkzTnUzOW9nLWpJNW0tcnhkcDh4UVBJT2hZeU9uSGgyX0VkWGRVVjdEZEZ6ci00dy1NWTU1OXBfbnlFY0Vycy1tSDVZeWlKdXAtMUNtUGR3U1dKMXlMc2pQMkNPYjV6ZGhYRmlsOHJVcHRKX2JaSWxNZHlTRkMtVzh6S1Zyc0x2eXh1V2ZsSEJNWWpHTFAxdGlpSFJoMU9QVG1TMDBOLTZEVDhvQWwzbHMwMm5TbEs4ZjBuMTZYcnNfSU9pZQ?oc=5\" target=\"_blank\">VRTX Q3 Deep Dive: New Product Launches and Pipeline Progress Shape Outlook</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Markets Financial Content</font>",
      "published": "2025-11-04T08:00:00+00:00",
      "source": "Markets Financial Content"
    },
    {
      "title": "It’s the Right Time for Vertex Pharmaceuticals to Look for Growth Drivers Beyond Tech Stocks - NAI500",
      "link": "https://news.google.com/rss/articles/CBMiwgFBVV95cUxOSXljRWtwSG10bXo5blQ5cmdzODU4R09Ga3hFSEg3TkdHUkd0bWxXeFdSSkZGY3lYQ0k4d05PVVpzVmZkS1phVHVNRFdpUzFWczAzRC1McVUybHhSTnRKSldkOEtPXy1wRFE2cWtzLXZPalZhN196WHdxZE15MmZ1N2Vabld3WWE3OFVNU21yWEJwMmYzWkdZVHNZcUV5YVpsUS1qd2RMZjduX1MyVTJoNXhQcG1uMGhhMV9qX0NyZm11Zw?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiwgFBVV95cUxOSXljRWtwSG10bXo5blQ5cmdzODU4R09Ga3hFSEg3TkdHUkd0bWxXeFdSSkZGY3lYQ0k4d05PVVpzVmZkS1phVHVNRFdpUzFWczAzRC1McVUybHhSTnRKSldkOEtPXy1wRFE2cWtzLXZPalZhN196WHdxZE15MmZ1N2Vabld3WWE3OFVNU21yWEJwMmYzWkdZVHNZcUV5YVpsUS1qd2RMZjduX1MyVTJoNXhQcG1uMGhhMV9qX0NyZm11Zw?oc=5\" target=\"_blank\">It’s the Right Time for Vertex Pharmaceuticals to Look for Growth Drivers Beyond Tech Stocks</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">NAI500</font>",
      "published": "2025-10-27T07:00:00+00:00",
      "source": "NAI500"
    }
  ],
  "stock": {
    "ticker": "VRTX",
    "currency": "USD",
    "latest": {
      "date": "2025-11-21",
      "close": 426.760009765625
    },
    "history": [
      {
        "date": "2025-11-13",
        "close": 434.5199890136719
      },
      {
        "date": "2025-11-14",
        "close": 437.1499938964844
      },
      {
        "date": "2025-11-17",
        "close": 434.0199890136719
      },
      {
        "date": "2025-11-18",
        "close": 435.5199890136719
      },
      {
        "date": "2025-11-19",
        "close": 421.0299987792969
      },
      {
        "date": "2025-11-20",
        "close": 422.32000732421875
      },
      {
        "date": "2025-11-21",
        "close": 426.760009765625
      }
    ],
    "name": "Vertex Pharmaceuticals Incorpor"
  }
}